IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 485, 27-37
Abstract
No abstract availableKeywords
Funding Information
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Ministry of Science and Technology, Taiwan
This publication has 50 references indexed in Scilit:
- AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net PhosphorylationCell Metabolism, 2013
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In VivoCell Metabolism, 2013
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stressNature, 2012
- AMP Is an Adenosine A1 Receptor AgonistJournal of Biological Chemistry, 2012
- Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancerOncogene, 2011
- Chondrodysplasia and Abnormal Joint Development Associated with Mutations in IMPAD1, Encoding the Golgi-Resident Nucleotide Phosphatase, gPAPPThe American Journal of Human Genetics, 2011
- Adenosine A1 receptor, a target and regulator of estrogen receptorα action, mediates the proliferative effects of estradiol in breast cancerOncogene, 2009
- The LKB1–AMPK pathway: metabolism and growth control in tumour suppressionNature Reviews Cancer, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfationProceedings of the National Academy of Sciences, 2008